Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for h (Q44604554)
Jump to navigation
Jump to search
scientific article published on October 5, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for h |
scientific article published on October 5, 2003 |
Statements
1 reference
Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for h (English)
1 reference
Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for high-throughput analysis (English)
Mohammed Jemal
1 reference
Satish Rao
1 reference
Michael Gatz
1 reference
Daisy Whigan
1 reference
1 October 2003
1 reference
795
1 reference
2
1 reference
273-289
1 reference
Identifiers
1 reference
1 reference